Eye Diseases "Treated" with Interoperable Medical Informatics
Launched by UNIVERSITY HOSPITAL MUENSTER · Jan 30, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The EyeMatics trial is focused on improving treatments for eye diseases that require injections into the eye, a procedure known as intravitreal injections. The goal of this study is to create a better system for sharing and analyzing patient data from clinical research, which will help doctors provide more personalized care for patients with eye conditions. Importantly, the trial involves input from patients themselves to ensure their experiences and concerns are considered in the research process.
If you are between the ages of 65 and 74 and have undergone the specific procedure for eye injections, you may be eligible to participate in this trial. Participants can expect to engage in a study that uses real patient data to better understand how effective current treatments are and to develop tools that help visualize and analyze this information. This research is being conducted at several hospitals, and by taking part, you could contribute to advancements in eye care that may benefit many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"
About University Hospital Muenster
University Hospital Münster is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and developing new therapeutic strategies. With a strong focus on collaboration and ethical research practices, University Hospital Münster plays a pivotal role in translating scientific discoveries into practical applications, fostering a culture of inquiry that benefits both the medical community and the patients it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tübingen, , Germany
Aachen, , Germany
Greifswald, , Germany
Chemnitz, Sachsen, Germany
Münster, , Germany
Leipzig, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported